Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 08 05 2020
accepted: 27 10 2020
entrez: 19 11 2020
pubmed: 20 11 2020
medline: 9 1 2021
Statut: epublish

Résumé

This study aimed to determine the association between umbilical cord leucine-rich alpha-2 glycoprotein (LRG) and fetal infection and investigate the underlying mechanism of LRG elevation in fetuses. We retrospectively reviewed the medical records of patients who delivered at Osaka University Hospital between 2012 and 2017 and selected those with histologically confirmed chorioamnionitis (CAM), which is a common pregnancy complication that may cause neonatal infection. The participants were divided into two groups: CAM with fetal infection (CAM-f[+] group, n = 14) and CAM without fetal infection (CAM-f[-] group, n = 31). Fetal infection was defined by the histological evidence of funisitis. We also selected 50 cases without clinical signs of CAM to serve as the control. LRG concentrations in sera obtained from the umbilical cord were unaffected by gestational age at delivery, neonatal birth weight, nor the presence of noninfectious obstetric complications (all, p > 0.05). Meanwhile, the LRG levels (median, Interquartile range [IQR]) were significantly higher in the CAM-f(+) group (10.37 [5.21-13.7] μg/ml) than in the CAM-f(-) (3.61 [2.71-4.65] μg/ml) or control group (3.39 [2.81-3.93] μg/ml; p < 0.01). The area under the receiver operating characteristic (ROC) curve of LRG for recognizing fetal infection was 0.92 (optimal cutoff, 5.08 μg/ml; sensitivity, 86%; specificity, 88%). In a mouse CAM model established by lipopolysaccharide administration, the fetal LRG protein in sera and LRG mRNA in the liver were significantly higher than those in phosphate-buffered saline (PBS)-administered control mice (p < 0.01). In vitro experiments using a fetal liver-derived cell line (WRL68) showed that the expression of LRG mRNA was significantly increased after interleukin (IL)-6, IL-1β, and tumor necrosis factor- alpha (TNF-α) stimulation (p < 0.01); the induction was considerably stronger following IL-6 and TNF-α stimulation (p < 0.01). In conclusion, LRG is an effective biomarker of fetal infection, and fetal hepatocytes stimulated with inflammatory cytokines may be the primary source of LRG production in utero.

Identifiants

pubmed: 33211747
doi: 10.1371/journal.pone.0242076
pii: PONE-D-20-13589
pmc: PMC7676652
doi:

Substances chimiques

Biomarkers 0
Glycoproteins 0
LRG1 protein, human 0
LRG1 protein, mouse 0
Lipopolysaccharides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0242076

Déclaration de conflit d'intérêts

I have read the journal's policy and the authors of this manuscript have the following competing interests: TN received a grant from SEKISUI MEDICAL CO., LTD. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Arthritis Rheumatol. 2015 May;67(8):2056-60
pubmed: 25917892
Neuro Endocrinol Lett. 2009;30(6):733-8
pubmed: 20038922
J Matern Fetal Neonatal Med. 2010 Aug;23(8):880-6
pubmed: 20441409
Pediatrics. 1993 Sep;92(3):431-5
pubmed: 8361798
Reprod Sci. 2011 Sep;18(9):900-7
pubmed: 21421895
Intensive Care Med. 2001 Jan;27(1):211-5
pubmed: 11280637
Clin Chem. 2001 Jun;47(6):1016-22
pubmed: 11375286
J Clin Diagn Res. 2016 May;10(5):DC13-7
pubmed: 27437213
J Obstet Gynaecol Res. 2013 Jan;39(1):26-30
pubmed: 22639902
Am J Reprod Immunol. 2015 Jun;73(6):568-76
pubmed: 25600281
World J Clin Cases. 2016 Jul 16;4(7):165-71
pubmed: 27458591
J Perinatol. 2014 Aug;34(8):611-5
pubmed: 24786381
Clin Chim Acta. 2011 May 12;412(11-12):1053-9
pubmed: 21338596
J Perinatol. 2010 Oct;30 Suppl:S21-30
pubmed: 20877404
Pak J Med Sci. 2015;31(3):527-31
pubmed: 26150837
N Engl J Med. 1999 Feb 11;340(6):448-54
pubmed: 9971870
J Matern Fetal Neonatal Med. 2003 Aug;14(2):85-90
pubmed: 14629087
Am J Obstet Gynecol. 2015 Oct;213(4 Suppl):S29-52
pubmed: 26428501
Infect Dis (Lond). 2015 Mar;47(3):117-24
pubmed: 25522182
Am J Perinatol. 2016 Jan;33(2):143-50
pubmed: 26352681
JAMA. 2000 Sep 20;284(11):1417-24
pubmed: 10989405
Immunol Med. 2018 Jun;41(2):62-67
pubmed: 30938267
Pediatr Res. 2018 Nov;84(5):757-764
pubmed: 30135596
Pediatr Infect Dis J. 2009 Dec;28(12):1052-6
pubmed: 19953725
Am J Obstet Gynecol. 2020 Jan;222(1):64.e1-64.e16
pubmed: 31351063
Inflamm Bowel Dis. 2012 Nov;18(11):2169-79
pubmed: 22374925
Obstet Gynecol. 2008 Sep;112(3):661-6
pubmed: 18757666
Lancet. 1999 May 22;353(9166):1798-9
pubmed: 10348018
Clin Chem. 2004 Feb;50(2):279-87
pubmed: 14752012
BMC Pregnancy Childbirth. 2011 Apr 07;11:26
pubmed: 21470433
Pediatr Infect Dis J. 2011 Nov;30(11):937-41
pubmed: 21654548
Am J Obstet Gynecol. 1994 May;170(5 Pt 1):1345-51
pubmed: 8178864
Am J Respir Crit Care Med. 2001 Aug 1;164(3):396-402
pubmed: 11500339
PLoS One. 2016 Sep 09;11(9):e0162672
pubmed: 27611322
J Matern Fetal Neonatal Med. 2017 Jun;30(12):1428-1433
pubmed: 27450900
Monogr Pathol. 1981;(22):67-132
pubmed: 7024790
World J Pediatr. 2012 May;8(2):101-8
pubmed: 22573419
Arch Dis Child Fetal Neonatal Ed. 2004 May;89(3):F229-35
pubmed: 15102726
Int J Cancer. 2011 Aug 15;129(4):1005-17
pubmed: 20949562
J Obstet Gynaecol Res. 2013 Jul;39(7):1236-41
pubmed: 23803006
J Reprod Immunol. 2000 Jul;47(2):185-96
pubmed: 10924750
Clin Chem. 2000 Oct;46(10):1583-7
pubmed: 11017935
Hypertension. 2018 Jul;72(1):24-43
pubmed: 29899139
Pediatrics. 2011 May;127(5):817-26
pubmed: 21518717
Ann Rheum Dis. 2010 Apr;69(4):770-4
pubmed: 19854709
PLoS One. 2015 Apr 10;10(4):e0122696
pubmed: 25860887
Am J Obstet Gynecol. 2006 Dec;195(6):1578-89
pubmed: 17132473
J Korean Med Sci. 2012 Jun;27(6):674-80
pubmed: 22690100
Clin Infect Dis. 2004 Jul 15;39(2):206-17
pubmed: 15307030
Biochem Biophys Res Commun. 2009 May 15;382(4):776-9
pubmed: 19324010
Arch Dis Child Fetal Neonatal Ed. 2006 Jan;91(1):F65-6
pubmed: 16371391
Clin Chem Lab Med. 2011 Feb;49(2):297-302
pubmed: 21126207
Am J Obstet Gynecol. 2009 Apr;200(4):430.e1-8
pubmed: 19318152
Electrophoresis. 1996 Mar;17(3):612-6
pubmed: 8740187
J Immunol. 2008 Mar 1;180(5):3492-501
pubmed: 18292576
Sci Rep. 2020 Feb 25;10(1):3384
pubmed: 32099022
J Crohns Colitis. 2017 Jan;11(1):84-91
pubmed: 27466171
Dev Med Child Neurol. 2008 Jan;50(1):19-24
pubmed: 18173624

Auteurs

Etsuko Kajimoto (E)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.
Department of Obstetrics and Gynecology, Japan Community Health Care Organization Osaka Hospital, Osaka, Japan.

Masayuki Endo (M)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.
Department of Children and Women's Health, Osaka University Graduate School of Medicine, Osaka, Japan.
Division of Health Science, Graduate School of medicine, StemRIM Institute of Regeneration-Inducting Medicine, Osaka University, Osaka, Japan.

Minoru Fujimoto (M)

Center for Intractable Immune Disease, Kochi Medical School, Kochi University, Kochi, Japan.

Shinya Matsuzaki (S)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.

Makoto Fujii (M)

Division of Health Science, Graduate School of medicine, StemRIM Institute of Regeneration-Inducting Medicine, Osaka University, Osaka, Japan.

Kazunobu Yagi (K)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.

Aiko Kakigano (A)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.

Kazuya Mimura (K)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.

Takuji Tomimatsu (T)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.

Satoshi Serada (S)

Center for Intractable Immune Disease, Kochi Medical School, Kochi University, Kochi, Japan.

Makoto Takeuchi (M)

Department of Pathology, Osaka Women's and Children's Hospital, Osaka, Japan.

Kiyoshi Yoshino (K)

Department of Obstetrics and Gynecology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.

Yutaka Ueda (Y)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.

Tadashi Kimura (T)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.

Tetsuji Naka (T)

Center for Intractable Immune Disease, Kochi Medical School, Kochi University, Kochi, Japan.
Laboratory of Immune Signal, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH